SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-024268
Filing Date
2021-05-06
Accepted
2021-05-05 18:14:23
Documents
65
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q acad-10q_20210331.htm   iXBRL 10-Q 2003474
2 EX-10.1 acad-ex101_299.htm EX-10.1 677435
3 EX-10.2 acad-ex102_302.htm EX-10.2 16501
4 EX-10.3 acad-ex103_300.htm EX-10.3 17161
5 EX-10.4 acad-ex104_301.htm EX-10.4 38270
6 EX-31.1 acad-ex311_6.htm EX-31.1 9472
7 EX-31.2 acad-ex312_10.htm EX-31.2 9215
8 EX-32.1 acad-ex321_9.htm EX-32.1 6327
9 EX-32.2 acad-ex322_7.htm EX-32.2 6385
  Complete submission text file 0001564590-21-024268.txt   7834048

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA acad-20210331.xsd EX-101.SCH 41763
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acad-20210331_cal.xml EX-101.CAL 55658
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acad-20210331_def.xml EX-101.DEF 99563
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20210331_lab.xml EX-101.LAB 297180
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20210331_pre.xml EX-101.PRE 230829
15 EXTRACTED XBRL INSTANCE DOCUMENT acad-10q_20210331_htm.xml XML 1417321
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 21894958
SIC: 2834 Pharmaceutical Preparations